Primus In News
Precision oncology gains ground as India clears targeted cancer therapies
25-12-2025
Nilaya Varma, Group CEO and Co-Founder,Primus Partners, highlights that the approvals represent a major step toward integrating outcome-based precision medicine into routine cancer care, with combination immunotherapies improving treatment outcomes for patient groups that previously had limited options.
Explore Related Insights
- Mumbai News: Maharashtra State Skills University Signs MOU With 18 Colleges
- India needs to boost maize production, adjust pricing for grain ethanol: report
- Primus Partners Launches Report Mapping India’s Care Economy as a $300 Billion Growth and Jobs Opportunity by 2030
- Govt to appoint an IT firm to implement a single window system
